FourThought Financial’s Collegium Pharmaceutical COLL Stock Holding History

FourThought Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Buy	+70	New	+$1.23K	﹤0.01%	1393
2022 Q1	–	Sell	-42	Closed	-$1K	–	1476
2021 Q4	$1K	Hold	42	–	–	﹤0.01%	1420
2021 Q3	$1K	Hold	42	–	–	﹤0.01%	1427
2021 Q2	$1K	Hold	42	–	–	﹤0.01%	1421
2021 Q1	$1K	Hold	42	–	–	﹤0.01%	1382
2020 Q4	$1K	Buy	+42	New	+$820	﹤0.01%	1358

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FourThought Financial's COLL Position: Q3 2022 in Review

FourThought Financial opened a new position in Collegium Pharmaceutical (COLL) in Q3 2022: 70 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1393 among its holdings. This is a return to the name: FourThought Financial previously reported a position in COLL as recently as Q4 2021.

FourThought Financial first reported a position in COLL in Q4 2020 and has held it in 6 quarters since. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

FourThought Financial held 70 shares of Collegium Pharmaceutical worth $1K as of Q3 2022.
Collegium Pharmaceutical was a new FourThought Financial position in Q3 2022.
Collegium Pharmaceutical made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1393 holding.
FourThought Financial first reported a position in Collegium Pharmaceutical in Q4 2020 and has held it in 6 quarters since.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.